Shailender Bhatia

Researcher Next ID · RN-008936

Researcher · Medicine

Cape Town, South Africa

Not currently recruitingFunding unknown

Research interests

Medicine

Environmental Science

Immunology and Microbiology

Polyomavirus and related diseases

Cancer Immunotherapy and Biomarkers

Bacteriophages and microbial interactions

CAR-T cell therapy research

Immunotherapy and Immune Responses

Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab
Cell · 2017 · https://doi.org/10.1016/j.cell.2017.09.028
Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma
New England Journal of Medicine · 2017 · https://doi.org/10.1056/nejmoa1709030
PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma
New England Journal of Medicine · 2016 · https://doi.org/10.1056/nejmoa1603702
Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial
The Lancet Oncology · 2016 · https://doi.org/10.1016/s1470-2045(16)30364-3
Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
New England Journal of Medicine · 2012 · https://doi.org/10.1056/nejmoa1200694

No projects listed.